已关闭
  • 顶部Banner位
  • 固定模块
设置
BPD
试用
AI
企业管理端
厂家
NebuSelect™ Recombinant Human CXCL4L1, hFc-tag
收藏 收藏
分享
需招商
Recombinant Human CXCL4L1, hFc-tag
原料试剂 研发实验室
价格
询价
品牌 辰辉创聚生物/Nebulabio
地区 中国,北京,北京市
货号 NBL-241813
产地 国产
选择规格
100ug
1mg
易享客服
辰辉创聚生物
北京辰辉创聚生物技术有限公司
中国北京
营业执照已审核
致力于为全球生物医药客户提供高品质原料。辰辉创聚生物依托深厚的蛋白质、免疫学及生物化学技术基础,深入研发并不断拓展,形成了以蛋白质现货、ELISA现货、诊断原料现货为主的丰富产品体系。
进入店铺
产品规格 图文详情 技术文档
产品规格
品牌名称
辰辉创聚生物/Nebulabio
货号
NBL-241813
国产/进口
国产
规格
100ug,1mg
储存条件
Store at 4°C for short-term, -20°C for long-term. Avoid repeated freezing and thawing cycles.
货源
新品
图文详情

Description:NebuSelect™ Recombinant Human CXCL4L1, hFc-tag(Cat#NBL-241813) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Phe31-Ser104.

Species:Human

Expression System:HEK293

Molecular Weight: The protein has a predicted MW of 35.01 kDa. Due to glycosylation, the protein migrates to 43-48 kDa based on Bis-Tris PAGE result.

Target Name:CXCL4L1

Target Information:Platelet factor-4 (CXCL4/PF-4) was the first chemokine shown to inhibit angiogenesis. CXCL4L1/PF-4var, recently isolated from thrombin-stimulated platelets, differing from authentic CXCL4/PF-4 in three carboxy-terminally located amino acids, was found to be more potent than CXCL4/PF-4 in inhibiting angiogenesis and tumor growth. Both glycosaminoglycans (GAG) and CXCR3 are implicated in the activities of the PF-4 variants.

Amino Acid Sequence: Phe31-Ser104

Purity:>95%

Endotoxin:<1EU/ug(LAL Method)

技术文档
没有您想要的资料?去索要
返回顶部